Author
Listed:
- Zhang Jenny J
(Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA)
- Sun Zhuoxin
(ECOG-ACRIN Statistical Center, Frontier Science and Technology Research Foundation, Brookline, MA 02446, USA)
- Yuan Han
(Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA)
- Wang Molin
(Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA)
AbstractProgression-free survival (PFS), defined as the time from randomization to progression of disease or death, has been indicated as an endpoint to support accelerated approval of certain cancer drugs by the U.S. FDA. The standard Kaplan–Meier (KM) estimator of PFS, however, can result in significantly biased estimates. A major source for the bias results from the substitution of censored progression times with death times. Currently, to ameliorate this bias, several sensitivity analyses based on rather arbitrary definitions of PFS censoring are usually conducted. In addition, especially in the advanced cancer setting, patients with censored progression and observed death times have the potential to experience disease progression between those two times, in which case their true PFS time is actually between those times. In this paper, we present two alternative nonparametric estimators of PFS, which statistically incorporate survival data often available for those patients who are censored with respect to progression to obtain less biased estimates. Through extensive simulations, we show that these estimators greatly reduce the bias of the standard KM estimator and can also be utilized as alternative sensitivity analyses with a solid statistical basis in lieu of the arbitrarily defined analyses currently used. An example is also given using an ECOG-ACRIN Cancer Research Group advanced breast cancer study.
Suggested Citation
Zhang Jenny J & Sun Zhuoxin & Yuan Han & Wang Molin, 2021.
"Alternatives to the Kaplan–Meier estimator of progression-free survival,"
The International Journal of Biostatistics, De Gruyter, vol. 17(1), pages 99-115, May.
Handle:
RePEc:bpj:ijbist:v:17:y:2021:i:1:p:99-115:n:9
DOI: 10.1515/ijb-2019-0095
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bpj:ijbist:v:17:y:2021:i:1:p:99-115:n:9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Peter Golla (email available below). General contact details of provider: https://www.degruyter.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.